Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The effect of diabetes on mild cognitive impairment (MCI) and its conversion to dementia remains controversial. We sought to examine whether diabetes and pre-diabetes are associated with MCI and accelerate the progression from MCI to dementia. RESEARCH DESIGN AND METHODS: In the Kungsholmen Project, 963 cognitively intact participants and 302 subjects with MCI (120 with amnestic MCI [aMCI ] and 182 with other cognitive impairment no dementia [oCIND]) age ≥75 years were identified at baseline. The two cohorts were followed for 9 years to detect the incident MCI and dementia following international criteria. Diabetes was ascertained based on a medical examination, hypoglycemic medication use, and random blood glucose level ≥11.0 mmol/l. Pre-diabetes was defined as random blood glucose level of 7.8–11.0 mmol/l in diabetes-free participants. Data were analyzed using standard and time-dependent Cox proportional-hazards models. RESULTS: During the follow-up period, in the cognitively intact cohort, 182 people developed MCI (42 aMCI and 140 oCIND), and 212 developed dementia. In the MCI cohort, 155 subjects progressed to dementia, the multi-adjusted hazard ratio (95% CI) of dementia was 2.87 (1.30–6.34) for diabetes, and 4.96 (2.27–10.84) for pre-diabetes. In a Kaplan-Meier survival analysis, diabetes and pre-diabetes accelerated the progression from MCI to dementia by 3.18 years. Diabetes and pre-diabetes were neither cross-sectionally nor longitudinally associated with MCI. CONCLUSIONS: Diabetes and pre-diabetes substantially accelerate the progression from MCI to dementia, and anticipate dementia occurrence by more than 3 years in people with MCI. The association of diabetes with the development of MCI is less evident in old people.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dysfunction of multiple organ systems manifests similarly in diabetes as it does during normal chronological ageing, but in diabetes this frequently occurs at a younger age [2–4].”
From Cellular senescence: at the nexus between ageing and diabetes (2019) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · cited 1×
“ADRDA) criteria (34), and to the National Institute of Neurological Disorders”
BackgroundDiagnostic and Statistical Manual of Mental Disorders (3rd ed. rev.)
Drake, M. (1988) · The American Journal of Occupational Therapy · doi:10.5014/ajot.42.10.683b · Cited by 5,240
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946 · cited 1×
“Different criteria and subdivisions of MCI have been proposed and modified over time (12).”
BackgroundSelf-citationRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · cited 3×
“This cohort included 120 aMCI subjects who had memory complaints and objective episodic memory impairment (14,24) and 182 oCIND subjects who had significant impairment in global cognitive performance, as defined in a previous report (15).”
BackgroundMethodSelf-citationGauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Self-citation. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · cited 2×
“Furthermore, many large population-based longitudinal studies have demonstrated an increased risk of dementia in people with diabetes (2), but the association of diabetes with Alzheimer’s disease is less evident in some studies (2,3).”
BackgroundMixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · cited 1×
“Interestingly, a clinicopathologic study suggested that there may be a shared predisposition for developing amyloid in both the pancreas and the brain (40).”
Background
Research works printed but not linked: 3
- Nordic Council on Medicines, 1985, Guidelines for ATC Classification
- World Health Organization, 1999, Definition, Diabetes and Classification of Diabetes Mellitus and Its Complications
- Xu W . Diabetes mellitus and the risk of dementia: a population-based study. Karolinska Institutet. The frame of the thesis available at http://diss.kib.ki.se/2008/978–91-7357–516-4. Accessed 16 May 2008
Cited by
Items 201–264 of 264
Ramlall, S. (2014) · Cited by 3
Nutrient signaling pathways regulate amyloid clearance and synaptic loss in Alzheimer’s diseasePreprint
Mondal, M., Bali, J., Tzioras, M., Paolicelli, R. C., Jawaid, A., Malnar, M., Dominko, K., Udayar, V., Halima, S. B., Vadodaria, K. C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.13.381186 · Cited by 3
“These results are consistent with previous reports on how mid-life diabetes, obesity and hyperlipidemia contribute to higher risk for AD and dementia (Kivipelto et al., 2005; Meyer et al., 2000; Profenno et al., 2010; Xu et al., 2010).”
ResultE, A. M. C. (2014) · African Journal of Psychiatry · doi:10.4172/psychiatry.1000170 · Cited by 2
Liu, Z., Huang, H., & Zhao, L. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01324-1 · Cited by 2
Rajamaki, B., Braithwaite, B., Hartikainen, S. A., & Tolppanen, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240490 · Cited by 2
“18 , 45 , 46 We set our study parameters to capture the changes in the two cohorts during this period and using the LDA method found different patterns of diagnoses among those with and without AD.”
MethodSakakibara, S., Dove, A. E., Dunk, M. M., Fastbom, J., Grande, G., Akenine, U., & Xu, W. (2025) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2025.105594 · Cited by 2
Self-citationTripathi, S. M., Shiells, H., Waymont, J. M. J., Staff, R. T., Schelter, B. O., Bentham, P., Wischik, C. M., & Murray, A. D. (2026) · Current Alzheimer Research · doi:10.2174/0115672050399596251106033110 · Cited by 2
GLP-1 and Parkinson’s Disease: A Comprehensive Review of Biology, Mechanisms and Efficacy
Mezabrovschi, R., Gegg, M. E., & Schapira, A. H. V. (2026) · Cells · doi:10.3390/cells15090804 · Cited by 3
“AD has been described as exhibiting features of ‘type 3 diabetes’ due to strong links between brain insulin resistance, oxidative stress, tau hyperphosphorylation, dysregulated amyloid processing, and neuronal loss [135–137].”
Vaskularni kognitivni upad in vaskularna demenca
Ovčar, K., Potočnik, J., & Rakuša, M. (2017) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1543 · Cited by 3
Cognitive impairment in patients with diabetes mellitus in the conditions of COVID-19
Zherdova, N. (2021) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.17.5.2021.238525 · Cited by 6
Alzheimer’s Disease: A Clinical Perspective
Xu, W., Marseglia, A., Ferrari, C., & Wang, H. (2013) · InTech eBooks · doi:10.5772/54539 · Cited by 3
Self-citationDementia and Systemic Disorders
Molano, J. R. V., & Kelley, B. J. (2013) · Wiley eBooks · doi:10.1002/9781118414019.ch4 · Cited by 3
Evaluation of the injured eye.
Selezinka, W. (1988) · PubMed · Cited by 2
Zherdova, N. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.13.5.2017.110021 · Cited by 2
Is Alzhezimer’s disease a New Type Diabetes? Crosstalk between two serious disorders: review
Dobosz, M., Rudziński, G., Chilimoniuk, Z., Więsyk, P. J., Kusak, N., & Chałupnik, A. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.13.03.017 · Cited by 2
Singh, J., Dhokne, M. D., Kumar, D., Datusalia, A. K., & Jangra, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13195-0.00011-9 · Cited by 1
Regional Brain Structure Alterations in Diabetes but Not Prediabetes
Wang, L., Lin, H., Zhao, Z., Chen, L., Wu, L., Liu, T., Li, J., Huang, C., Lo, C. Z., & Gao, X. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf248 · Cited by 1
Chen, T., Qiu, H.-N., Zhang, X.-P., Wu, F., Liu, Y.-L., Li, J., & Lin, J.-N. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1690654 · Cited by 1
“Diabetes markedly elevates the risk of mild cognitive impairment (MCI) and dementia (3, 4), and accelerates the progression of MCI to Alzheimer ’ s disease (AD) and dementia (5, 6).”
Yin, Q., Nie, X., Luo, H., Yang, G., Bu, J., Jiang, D., Xu, N., Zhang, Y., & Zhuang, P. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158607 · Cited by 1
The influence of diabetes mellitus II on cognitive performance
Silva, J. L. D., Ribeiro, L. T. C., dos Santos, N. R. P., Beserra, V. C. A. D. S., & Fragoso, Y. D. (2012) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642012dn06020003 · Cited by 1
The Altered Cerebral Homeostasis with Aging in Diabetes Mellitus and Cognitive Decline
Nikhra, V. (2018) · Gerontology & Geriatrics Studies · doi:10.31031/ggs.2018.03.000556 · Cited by 1
“Mild cognitive impairment is the stage before dementia, and when it is accompanied by DM, progression to dementia is accelerated [132].”
BackgroundType 2 Diabetes Mellitus Management in Older Adults with Dementia
Sohail, M., James, K., & Munshi, M. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-46398-4_6 · Cited by 2
COVID-19-Related Stressors and the Role of Cognitive Assessment
Ma, F., Hashmi, A. Z., & Liu, C. Y. (2021) · Neurological Sciences and Neurosurgery · doi:10.47275/2692-093x-115 · Cited by 1
Alzheimer Disease-Type 3 Diabetes: Traditional Review
Elkaan, B. T., Elmacıoğlu, F., & Ülker, M. T. (2023) · Turkiye Klinikleri Journal of Health Sciences · doi:10.5336/healthsci.2022-94043 · Cited by 1
24 Life course epidemiology in dementia - state of the art
Fratiglioni, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.01.042 · Cited by 1
Self-citationInfluence of Selected Diets on Neural Insulin Activity and Cognitive Function
Parrott, M. D. (2014) · TSpace (University of Toronto) · Cited by 1
Qi, W., Long, Y., Li, Z., Zhao, Z., Shi, J., Xie, W., Wang, L., Tan, Y., Zhou, T., Jiang, P., et al. (2024) · eLife · doi:10.7554/elife.99462.1 · Cited by 1
Sian, M., & Lee, T.-S. W. (2013) · InTech eBooks · doi:10.5772/54289
“MCI is an unstable clinical construct where some patients convert (MCI-converters) while others remain rela‐ tively stable (MCI non-converters).”
The use of fiber tractography for identifying patients with Alzheimer’s disease
Dong, K.-R., Goo, E.-H., Lee, J., Chung, W.-K., & Park, Y. S. (2013) · Journal of the Korean Physical Society · doi:10.3938/jkps.62.165
Social Service Information for Dementia Patients
Jang, J.-H. (2012) · Journal of Korean Diabetes · doi:10.4093/jkd.2012.13.3.157
Avaliação neuropsicológica da tomada de decisão no comprometimento cognitivo leve
Flaborea, R. S. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.47.2015.tde-03062015-115402
Metabolic modifications associated with memory deficits
Rial, A. C. F. D. L. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Risk of Alzheimer's Disease Among Older Hispanic/Latinos with Diabetes
Bianco, K. (2016) · ScholarWorks (Walden University)
Risikofaktoren für leichte kognitive Beeinträchtigung bei Patienten in Hausarztpraxen
Bohlken, J., & Kostev, K. (2017) · Monitor Versorgungsforschung · doi:10.24945/mvf.01.17.1866-0533.1999
Prediabetes: An Update and a Rational for Diagnostic Confusion
Bakıner, O., Bozkırlı, E., Aksöyek, A., & Özşahin, A. K. (2019) · Turkish Journal of Family Medicine & Primary Care · doi:10.21763/tjfmpc.528045
Gamal, W. M., Abbas, M. A. A., & Mohamed, A. A. (2018) · Journal of Vascular Medicine & Surgery · doi:10.4172/2329-6925.1000369
Prevalence and factors associated with mild cognitive impairment among older Malaysians
Kamarolzaman, K. (2015) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)
Dove, A. E. (2019) · Työväentutkimus Vuosikirja
Haq, A. I., Sarkar, M., Roy, S., & Ahmed, A. U. (2020) · Bangladesh Journal of Psychiatry · doi:10.3329/bjpsy.v31i1.45368
Midlife diabetes and the risk of dementia
Dyer, A. H., & Kennelly, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00006-9
Physical activity during pregnancy alters gene expression in neonatal tissue
Reynolds, L. J., Vsevolozhskaya, O. A., Rice, B. B., Chavan, N. R., Dugan, A. J., Maddox, H. F., Preston, J. D., DeHoff, L. B., O’Brien, J., & Pearson, K. J. (2021) · Physiology International · doi:10.1556/2060.2021.00003
Impaired Glucose Tolerance in Aging as a Risk Factor for Cognitive Dysfunction
Burch, M. (2021) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
Diabetes Management in Older Adults
Schneider, L. M., Feliciano, L., & Beutell, N. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_812
ASSESSMENT OF COGNITIVE FUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Saha, S., Vijayadas, V., Preethi, B. L., & Kalra, P. (2022) · Indian Journal Of Applied Research · doi:10.36106/ijar/7802885
Diabetes Management in Older Adults
Schneider, L. M., Feliciano, L., & Beutell, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_812-1
Yin, Q., Li, L., Bu, J., Meng, F., Liu, P., Li, Y., Wang, B., Guo, H. W., Zhang, J., Zhuang, P., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4806434
Qi, W., Long, Y., Li, Z., Zhao, Z., Shi, J., Xie, W., Wang, L., Tan, Y., Zhou, T., Liang, M., et al. (2025) · eLife · doi:10.7554/elife.99462.2
Impact of treatment modality on cognition in older adults with type 2 diabetes mellitus
Chutia, P., & Tripathi, S. M. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1859_24
“[5] The commonly explained pathogenic mechanisms for cognitive impairment in patients with diabetes are insulin resistance, hyperglycaemia, chronic inflammation, vascular changes, and oxidative stress.”
Neuroimaging techniques in the study of type 2 diabetes
Rai, M. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-32848-0.00019-4
Frison, É. (2019) · theses.fr (ABES) · doi:10.70675/a527bd03zb814z44e5z8848z942b662a0847 · Cited by 2
Impact of glucidic metabolism disorders on cognition
Mouchref, S. (2022) · theses.fr (ABES) · doi:10.70675/949a4bcaz5dd1z48c2z8323za440f7337e80
Diabetes, prediabetes, and mild cognitive impairment among older adults: the Hitachi Health Study II
Fukunaga, A., Ito, A., Inoue, Y., Inada, H., Nakagawa, T., Yamamoto, S., Konishi, M., & Mizoue, T. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02720-6
“Additionally, previous studies defined diabetes based on self-report [7– 9] and/or a single glycemic marker (FPG [10–13] or HbA1c [5, 14]), which have been shown to overlook 37% and 29% of diabetes cases, respectively [15 ].”
InfluentialComparative Analysis of Radish Varieties: Effects on Sugar Metabolism and Antioxidant Enzymes
Akgün, F., & Eruygur, N. (2026) · Bulletin of Biotechnology · doi:10.51539/biotech.1917286
Burke, S. J., Galvin, D. M., Nolan, Y. M., Schellekens, H., & Henry, R. J. (2026) · Neurotrauma Reports · doi:10.1177/2689288x261456994
Claffey, P., Briggs, R., Kennelly, S., & O’Neill, D. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-21928-2_15
Jin, H., Yu, M., & Initiative, F. T. A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261500770
Liy-Salmerón, G., & Azrad, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408139-0.00010-9
Metadata
- Authors
- Xu, W., Caracciolo, B., Wang, H.-X., Winblad, B., Bäckman, L., Qiu, C., & Fratiglioni, L.
- Affiliations
- Stockholm University (SE)
- Corresponding author
- Xu, Weili
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-16
- Volume
- 59
- Issue
- 11
- Pages
- 2928-2935
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963552
- OpenAlex
- W2138030160
- Cited by
- 260
- References
- 47
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 21 · 2023: 18 · 2022: 14 · 2021: 22 · 2020: 19 · 2019: 18 · 2018: 14 · 2017: 13 · 2016: 9 · 2015: 15 · 2014: 26 · 2013: 20 · 2012: 13
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Karolinska Institutet
- Vetenskapsrådet
- Swedish Brain Power
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- prediabetes, mild cognitive impairment, dementia, conversion to dementia, amnestic mild cognitive impairment, older adults, incident dementia
- MeSH terms
- Aged, Aged, 80 and over, Amnesia, Cognition Disorders, Cross-Sectional Studies, Dementia, Diabetes Mellitus, Educational Status, Female, Follow-Up Studies, Humans, Male, Prediabetic State, Severity of Illness Index, Incidence, Disease Progression, Risk Assessment, Stroke, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

